Mettler-Toledo International (NYSE:MTD) Issues FY 2025 Earnings Guidance

Key Points

• Mettler-Toledo International has issued FY 2025 EPS guidance between $42.100 and $42.600, exceeding the consensus estimate of $41.512, while revenue guidance is steady at $3.9 billion.
• The company's stock recently traded down 2.5% to $1,234.65, amidst volatility, despite a market capitalization of $25.66 billion.
• Various analysts have updated their ratings on Mettler-Toledo, with Citigroup and UBS upgrading their ratings to buy, while the stock currently holds a consensus rating of Hold.

Mettler-Toledo International (NYSE:MTD - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 42.100-42.600 for the period, compared to the consensus EPS estimate of 41.512. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. Mettler-Toledo International also updated its Q3 2025 guidance to 10.550-10.750 EPS.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on MTD shares. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price target for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the company an "outperform" rating in a research report on Tuesday, July 8th. Finally, Barclays initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $1,298.50.

Mettler-Toledo International Stock Down 2.5%

MTD stock traded down $31.25 during mid-day trading on Thursday, reaching $1,234.65. 302,600 shares of the stock traded hands, compared to its average volume of 175,853. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93. The firm has a market capitalization of $25.66 billion, a PE ratio of 30.79, a P/E/G ratio of 3.89 and a beta of 1.37. The business has a 50-day moving average of $1,189.96 and a two-hundred day moving average of $1,194.60.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.57 by $0.52. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. On average, equities research analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.94% of the company's stock.

Institutional Trading of Mettler-Toledo International

A hedge fund recently raised its stake in Mettler-Toledo International stock. Geneos Wealth Management Inc. raised its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 83.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66 shares of the medical instruments supplier's stock after purchasing an additional 30 shares during the quarter. Geneos Wealth Management Inc.'s holdings in Mettler-Toledo International were worth $78,000 at the end of the most recent reporting period. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.